Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors
Authors:
- Minu M BhuniaMBMinu M Bhunia
- Christopher M StehnCSChristopher M Stehn
- Tyler A JubenvilleTJTyler A Jubenville
- Ethan L NovacekENEthan L Novacek
- Alex T LarssonALAlex T Larsson
- Suganth SuppiahSSSuganth Suppiah
- Germán L Velez-ReyesGVGermán L Velez-Reyes
- Kyle B WilliamsKWKyle B Williams
- Mark SokolowskiMSMark Sokolowski
- Rory L WilliamsRWRory L Williams
Open Access
- 1 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 6 (1) , vdae188
Abstract
Malignant peripheral nerve sheath tumors (MPNST) can arise from atypical neurofibromas (ANF). Loss of the polycomb repressor complex 2 (PRC2) is a common event. Previous studies on PRC2-regulated genes in MPNST used genetic addback experiments in highly aneuploid MPNST cell lines which may miss PRC2-regulated genes in NF1-mutant ANF-like precursor cells. A set of PRC2-regulated genes in human Schwann cells has not been defined. We hypothesized PRC2 loss has direct and indirect effects on gene expression resulting in MPNST, so we sought to identify PRC2-regulated genes in immortalized human Schwann cells (iHSCs). We engineered NF1-deficient iHSCs with loss of function SUZ12 or EED mutations. RNA sequencing revealed 1,327 differentially expressed genes to define PRC2-regulated genes. To investigate MPNST pathogenesis we compared genes in iHSCs to consistent gene expression differences between ANF and MPNSTs. Chromatin immunoprecipitation sequencing was used to further define targets. Methylome and proteomic analyses were performed to further identify enriched pathways. We identified potential PRC2-regulated drivers of MPNST progression. Pathway analysis indicates many upregulated cancer-related pathways. We found transcriptional evidence for activated Notch and Sonic Hedgehog signaling in PRC2-deficient iHSCs. Functional studies confirm Notch signaling is active in MPNST cell lines, patient-derived xenografts, and transient cell models of PRC2 deficiency. A combination of MEK and γ-secretase inhibition shows synergy in MPNST cell lines. We identified PRC2-regulated genes and potential drivers of MPNSTs. Our findings support the Notch pathway as a druggable target in MPNSTs. Our identification of PRC2-regulated genes and pathways could result in more novel therapeutic approaches.Keywords
Funding Information
- American Cancer Society Research Professor (#123939)
- National Institute on Neurological Disease and Stroke (R01NS115438)
- National Cancer Institute (R01NS086219)
- Pre-Clinical Research Award Neurofibromatosis Research Initiative
- Boston Children’s Hospital (GENFD0001769008)
- Drug Discovery Initiative
- Children’s Tumor Foundation
- Neurofibromatosis Therapeutic Acceleration Program
- Johns Hopkins University School of Medicine
This publication has 67 references indexed in Scilit:
- The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular LymphomaCell, 2011
- Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial DesignMolecular Cancer Therapeutics, 2010
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylationNature Genetics, 2008
- Genome-wide maps of chromatin state in pluripotent and lineage-committed cellsNature, 2007
- The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell DifferentiationMolecular and Cellular Biology, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Notch and Schwann cell transformationOncogene, 2004
- A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctionsThe EMBO Journal, 2002
- Activation of Notch signaling in human colon adenocarcinomaInternational Journal of Oncology, 1992